Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 05.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Unternehmen & Branche
| Name | CALLAN JMB INC. |
|---|---|
| Ticker | CJMB |
| CIK | 0002032545 |
| Boerse | US |
| Sektor | Industrials |
| Industrie | Integrated Freight & Logistics |
| SIC | 7389 · Services-Business Services, NEC |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 4,4 Mio. USD |
| Beta | 0,90 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 5,723,178 | -7,966,366 | -1.82 | 5,775,701 | 2,328,039 |
| 2025-09-30 | 10-Q | 1,446,917 | -2,731,341 | -0.61 | 7,736,180 | 4,175,652 |
| 2025-06-30 | 10-Q | 1,666,309 | -1,397,523 | -0.31 | 8,965,681 | 5,825,287 |
| 2025-03-31 | 10-Q | 1,449,377 | -1,240,590 | -0.32 | 8,455,666 | 6,807,581 |
| 2024-12-31 | 10-K | 6,563,412 | -2,293,648 | -0.87 | 5,082,549 | 3,173,358 |
| 2024-09-30 | 10-Q | 1,435,376 | -804,987 | -0.27 | 4,414,411 | |
| 2024-06-30 | 10-Q | 1,985,768 | -112,476 | -0.04 | 5,219,398 | |
| 2024-03-31 | 10-Q | 1,790,521 | -81,133 | -0.03 | 5,219,398 | |
| 2023-12-31 | 10-K | 13,202,459 | 2,181,108 | 9,705,529 | 8,795,260 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Croyle David J | Officer, 10% Owner, Chief Medical Officer | Open Market Purchase | 10,195 | 1.75 | 17,841.25 | +135,6% | |
| 2026-03-06 | Croyle David J | Officer, 10% Owner, Chief Medical Officer | Open Market Purchase | 14,805 | 1.76 | 26,086.41 | +198,2% | |
| 2025-12-30 | Dial Gerald | Director | Open Market Purchase | 1,539 | 1.20 | 1,846.80 | +14,0% | |
| 2025-12-30 | Dial Gerald | Director | Open Market Purchase | 461 | 1.22 | 562.42 | +4,3% | |
| 2025-12-16 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 5,000 | 1.73 | 8,650.00 | +65,7% | |
| 2025-12-15 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 10,810 | 1.70 | 18,377.00 | +139,6% | |
| 2025-12-12 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 4,926 | 1.75 | 8,620.50 | +65,5% | |
| 2025-12-11 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 62 | 1.79 | 110.98 | +0,8% | |
| 2025-12-11 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 30,856 | 1.65 | 50,912.40 | +386,9% | |
| 2025-12-10 | Williams Wayne D | Director, Officer, 10% Owner, CEO, Chairman and President | Open Market Purchase | 13,689 | 1.65 | 22,586.85 | +171,6% | |
| 2025-12-09 | Duke Liberty Smith | Director | Open Market Purchase | 612 | 1.52 | 930.24 | +7,1% | |
| 2025-12-08 | Duke Liberty Smith | Director | Open Market Purchase | 900 | 1.56 | 1,404.00 | +10,7% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.